Roche urges caution in Posicor switch after 4 patients had severe reactions

Article Abstract:

Roche Holdings AG urges caution in switching from Posicor to different hypertension medicines. Roche withdrew the drug worldwide because of potentially dangerous interactions with about 25 other widely used medicines. Reseachers at the Oregon Poison Center at Oregon Health Sciences University, Portland will publish a report on the subject next month in the Journal of the American Medical Association. Oregon researchers found that when patients switched to other calcium channel blockers there were severe reactions and death in one case.

Comment:

Urges caution in switching from Posicor to other hypertension medicines

Product information, Switzerland, Company Planning/Goals, Antihypertensives NEC, Antihypertensive agents, Roche Holding Ltd.

---

Phytopharm grants Pfizer rights to obesity drug

Article Abstract:

Pfizer Inc. has obtained licensing rights for an anti-obesity drug from Phytopharm PLC in a deal that is valued at as much as $32 million. Phytopharm, which has been searching through jungles around the world for plant-derived extracts, has performed successful tests of the drugs on animals. Industry analysts have said that such research is the wave of the future in the drugs and pharmaceutical industry since only 5% of the 250,000 plant species worldwide have been examined for their medicinal properties.

Comment:

Has sold licensing rights for an anti-obesity drug to Pfizer Inc.

United Kingdom, United States, Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Strategic alliances, Licensing/Sales Agreements, Pharmaceutical Preparations, Drugs, Pfizer Inc., Phytopharm plc

---

Similar abstracts:

• Abstracts: Adding up the pluses and minuses of buying or leasing a PC. G3: Blue and white and different all over, except the name
• Abstracts: IBM targets Sun with guerrilla tactics. P&G to ad agencies: please rewrite our old formulas
• Abstracts: Cendant projects bigger decline in 1998 profit. Cendant's board split over fraud woes. Wal-Mart to build a test supermarket in bid to boost grocery-industry share
• Abstracts: Inacom to purchase Vanstar in $480 million stock swap. Xerox recruits IBM's Firestone as retail chief, rejoining ex-boss
• Abstracts: New profits in old bottles; companies find bonus in drugs that cure several ills. SmithKline to sell off units for $1.97 billion

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.